Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Catalyst
Pharma
FDA signs off on Santhera's muscular dystrophy drug Agamree
The FDA approval of Santhera’s Agamree to treat DMD is just a start. The company is anxious to see how many disorders the corticosteroid can treat.
Kevin Dunleavy
Oct 27, 2023 8:23am
Catalyst one-ups Jacobus, FDA in Firdapse exclusivity appeal
Oct 1, 2021 12:11pm
Pfizer, Zogenix, Catalyst, Rigel raise prices to start July
Jul 1, 2021 10:16am
Catalyst sues FDA over 'capricious' approval for rival
Jun 12, 2019 10:45am
Catalyst's $375K Firdapse could get off-label competition
May 7, 2019 12:02pm
Patient group urges BIO to boot Catalyst over $375K Firdapse price
Mar 7, 2019 10:20am
